Evidence map›Paper›PMID 36835391›Full record

ArticleInternational journal of molecular sciences2023

An Unexpected Enzyme in Vascular Smooth Muscle Cells: Angiotensin II Upregulates Cholesterol-25-Hydroxylase Gene Expression.

Kinga Bernadett Kovács, Laura Szalai, Pál Szabó, Janka Borbála Gém, Szilvia Barsi, Bence Szalai, Bernadett Perey-Simon, Gábor Turu, András Dávid Tóth, Péter Várnai and 2 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 5 citations in OpenAlex.

  1. Direct Vascular Effects of Angiotensin II (A Systematic Short Review).International journal of molecular sciences · 2024
    Pooled it
  2. Dexamethasone regulates gene expression in chondrocytes through MKP-1 and downregulates cholesterol hydroxylases CH25H and CYP7B1.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2025
    Article
  3. Article
  4. 25-Hydroxycholesterol in health and diseases.Journal of lipid research · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Kinga Bernadett KovácsDepartment of Physiology, Semmelweis University, 1094 Budapest, Hungary.
Laura SzalaiDepartment of Physiology, Semmelweis University, 1094 Budapest, Hungary.ORCID 0000-0002-4780-7624
Pál SzabóResearch Center for Natural Sciences, Center for Structural Study, MS Metabolomics Laboratory, 1117 Budapest, Hungary.ORCID 0000-0003-2260-4641
Janka Borbála GémDepartment of Physiology, Semmelweis University, 1094 Budapest, Hungary.
Szilvia BarsiDepartment of Physiology, Semmelweis University, 1094 Budapest, Hungary.ORCID 0000-0002-8779-2383
Bence SzalaiDepartment of Physiology, Semmelweis University, 1094 Budapest, Hungary.
Bernadett Perey-SimonDepartment of Physiology, Semmelweis University, 1094 Budapest, Hungary.
Gábor TuruDepartment of Physiology, Semmelweis University, 1094 Budapest, Hungary.ORCID 0000-0002-4421-3812
András Dávid TóthDepartment of Physiology, Semmelweis University, 1094 Budapest, Hungary.ORCID 0000-0003-2746-9370
Péter VárnaiDepartment of Physiology, Semmelweis University, 1094 Budapest, Hungary.
László HunyadyDepartment of Physiology, Semmelweis University, 1094 Budapest, Hungary.
András BallaDepartment of Physiology, Semmelweis University, 1094 Budapest, Hungary.
Semmelweis University · HU

Funding

Hungarian Academy of Sciences Premium Postdoctoral Fellowship Program-460044Hungarian National Research, Development and Innovation Fund K139231Hungarian National Research, Development and Innovation Fund NKFI K116954Hungarian National Research, Development and Innovation Fund NVKP_16-1-2016-0039Hungarian National Research, Development and Innovation Fund VEKOP-2.3.2-16-2016-00002Semmelweis 250+ Excellence PhD Scholarship EFOP-3.6.3-VEKOP-16-2017-00009
6 · The paper itself

Abstract

Angiotensin II (AngII) is a vasoactive peptide hormone, which, under pathological conditions, contributes to the development of cardiovascular diseases. Oxysterols, including 25-hydroxycholesterol (25-HC), the product of cholesterol-25-hydroxylase (CH25H), also have detrimental effects on vascular health by affecting vascular smooth muscle cells (VSMCs). We investigated AngII-induced gene expression changes in VSMCs to explore whether AngII stimulus and 25-HC production have a connection in the vasculature. RNA-sequencing revealed that

Indexed as

Angiotensin IIMuscle, Smooth, VascularSteroid HydroxylasesAnimalsCells, CulturedChromatography, LiquidGene ExpressionMyocytes, Smooth MuscleRatsTandem Mass SpectrometryAngiotensin IIcholesterol 25-hydroxylaseSteroid Hydroxylases25-hydroxycholesterolangiotensin IIatherosclerosischolesterol-25-hydroxylasevascular smooth muscle cell

Identifiers

PMID36835391
PMCPMC9965395
OpenAlexW4321096184

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.